-
1
-
2
-
3
-
4
Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy
Published 2020-01-01“…One of the standards for cancer treatment is cancer immunotherapy which treats both primary and metastasized tumors. …”
Get full text
Article -
5
-
6
Natural killer cell engagers for cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
7
-
8
ATM in immunobiology: From lymphocyte development to cancer immunotherapy
Published 2025-02-01“…Finally, this review highlights the emerging role of ATM in cancer immunotherapy, where its inhibition shows promise in enhancing immune checkpoint blockade therapy. …”
Get full text
Article -
9
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Published 2025-01-01Subjects: Get full text
Article -
10
-
11
-
12
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
Published 2021-01-01“…Here, we explore the current status of the cancer immunotherapy approaches based on manipulation of TLR signaling to provide a perspective of the underlying rationales and potential clinical applications. …”
Get full text
Article -
13
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01Subjects: Get full text
Article -
14
Potential and development of cellular vesicle vaccines in cancer immunotherapy
Published 2025-01-01Get full text
Article -
15
Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy
Published 2025-01-01“…The formulation significantly restored T-cell function compared to the BMS-1166 treatment.Conclusion: These results provide preliminary evidence indicating that BMS-T7 may have the potential to deliver drugs to breast cancer cells via active targeting and hold great promise in cancer immunotherapy drug delivery applications.Keywords: PD-L1, BMS-1166, immunotherapy, breast cancer, micelles…”
Get full text
Article -
16
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
Published 2025-02-01Get full text
Article -
17
Biometallic ions and derivatives: a new direction for cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
18
Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
19
What’s in a name? Memory NK cells for cancer immunotherapy
Published 2025-01-01Get full text
Article -
20
CRISPR/Cas9: Role of genome editing in cancer immunotherapy
Published 2024-06-01Get full text
Article